» Articles » PMID: 17890243

MethyCancer: the Database of Human DNA Methylation and Cancer

Overview
Specialty Biochemistry
Date 2007 Sep 25
PMID 17890243
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is ranked as one of the top killers in all human diseases and continues to have a devastating effect on the population around the globe. Current research efforts are aiming to accelerate our understanding of the molecular basis of cancer and develop effective means for cancer diagnostics, treatment and prognosis. An altered pattern of epigenetic modifications, most importantly DNA methylation events, plays a critical role in tumorigenesis through regulating oncogene activation, tumor suppressor gene silencing and chromosomal instability. To study interplay of DNA methylation, gene expression and cancer, we developed a publicly accessible database for human DNA Methylation and Cancer (MethyCancer, http://methycancer.genomics.org.cn). MethyCancer hosts both highly integrated data of DNA methylation, cancer-related gene, mutation and cancer information from public resources, and the CpG Island (CGI) clones derived from our large-scale sequencing. Interconnections between different data types were analyzed and presented. Furthermore, a powerful search tool is developed to provide user-friendly access to all the data and data connections. A graphical MethyView shows DNA methylation in context of genomics and genetics data facilitating the research in cancer to understand genetic and epigenetic mechanisms that make dramatic changes in gene expression of tumor cells.

Citing Articles

CancerMHL: the database of integrating key DNA methylation, histone modifications and lncRNAs in cancer.

Du P, Chen Y, Li Q, Gai Z, Bai H, Zhang L Database (Oxford). 2024; 2024.

PMID: 38613826 PMC: 11015892. DOI: 10.1093/database/baae029.


Biomedical Big Data Technologies, Applications, and Challenges for Precision Medicine: A Review.

Yang X, Huang K, Yang D, Zhao W, Zhou X Glob Chall. 2024; 8(1):2300163.

PMID: 38223896 PMC: 10784210. DOI: 10.1002/gch2.202300163.


Expanding adverse outcome pathways towards one health models for nanosafety.

Saarimaki L, Del Giudice G, Greco D Front Toxicol. 2023; 5:1176745.

PMID: 37692900 PMC: 10485555. DOI: 10.3389/ftox.2023.1176745.


CanMethdb: a database for genome-wide DNA methylation annotation in cancers.

Zhao J, Qian F, Li X, Yu Z, Zhu J, Yu R Bioinformatics. 2022; 39(1).

PMID: 36477791 PMC: 9825769. DOI: 10.1093/bioinformatics/btac783.


Prostate cancer in omics era.

Gholami N, Haghparast A, Alipourfard I, Nazari M Cancer Cell Int. 2022; 22(1):274.

PMID: 36064406 PMC: 9442907. DOI: 10.1186/s12935-022-02691-y.


References
1.
Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

2.
Nishiyama R, Qi L, Lacey M, Ehrlich M . Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer. Mol Cancer Res. 2005; 3(11):617-26. PMC: 1420408. DOI: 10.1158/1541-7786.MCR-05-0146. View

3.
Clark S, Melki J . DNA methylation and gene silencing in cancer: which is the guilty party?. Oncogene. 2002; 21(35):5380-7. DOI: 10.1038/sj.onc.1205598. View

4.
Wheeler D, Church D, Federhen S, Lash A, Madden T, Pontius J . Database resources of the National Center for Biotechnology. Nucleic Acids Res. 2003; 31(1):28-33. PMC: 165480. DOI: 10.1093/nar/gkg033. View

5.
Amoreira C, Hindermann W, Grunau C . An improved version of the DNA Methylation database (MethDB). Nucleic Acids Res. 2003; 31(1):75-7. PMC: 165540. DOI: 10.1093/nar/gkg093. View